Peer Review History
| Original SubmissionJune 28, 2023 |
|---|
|
PONE-D-23-20187Ameliorating the impairment of glucose utilization in a high-fat diet-induced obesity model through the consumption of Tucum-do-Cerrado (Bactris Setosa Mart.)PLOS ONE Dear Dr. Araújo, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Sep 28 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Anand Thirupathi Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: N/A Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Good efforts by the authors. Q1. Fig.1 is not called out in the results section. Since the body weight of rats are overlapping, a line graph would be more appropriate for better visualization. This should be considered. Q2. The author should provide the 95% confidence interval for all the p-values. Since the SEM has been used for plotting graphs, there are variations among groups which overlap with other groups, yet significantly different. These data are hidden and opaque to readers. Q3. Labelling of individual graphs of each figure and appropriate callouts should be done to enhance the readers' attention. Q4. Fig. 4,6, and 7. What does the word "mRNAr" indicates? Q5. Authors did not provide the primers for TNFa and IL1b. Q6. Fig2 A- GST activity significance value of HF/TUC is suspicious. This puts the authors conclusion "This response may be related to the improvement in the total antioxidant capacity of rats" in question. Please clarify the statistics Suggestion to author to refer for graphs https://clauswilke.com/dataviz/time-series.html Reviewer #2: High-fat diet fed rats were used in the manuscript, and the glucose utilization was impaired, which could be ameliorated with consumption of Tucum-do-Cerrado, investigation of the underlying mechanisms revealed the increased liver and muscle glucose uptake and oxidation. However, there are some issues to be done to improve the manuscript. 1. The powder of Tucum-do-Cerrado extraction was used for the diet supplements, and could ameliorate the glucose metabolism disorders induced by high-fat diet in the manuscript, and it can also protect tissues against iron-induced oxidative stress in the published work. It is wondering what main component of Tucum-do-Cerrado is protective, which could be discussed or referenced. 2. Although the freezing-dried Tucum-do-Cerrado extraction could induce the changes of muscle glycogen, it has no effects on fasting plasma glucose, body weight and insulin level, which is contrary to the reports in 2020 (doi: 10.1039/D0FO01912G.), is it due to the different dosage? What is the relative dose of the extraction for human beings? 3. In the section of Results, there was no description of Figure 1, which should be inserted in corresponding position. 4. In table 2 and 3, there are labels of a, b or c in graphs, which means the p value? It is recommended to add the information in figure legends respectively. 5. In table 3, check the position of ±, if there is no error for its position, what it represents should be listed in figure legends. Moreover, there are significant changes according to p value < 0.05 such as 0.021 or 0.018, but the description in the main text is no alteration, which should be checked and corrected. 6. In figure 4a, 6a and 7b, what does “r” in “mRNAr” mean? The spelling of B-actin should be β-actin. 7. In the top left corner of the column in figures, there are illustrations of diet, Tucum, diet x Tucum with data, which should also be explained in figure legends. 8. Confirm it is glucosidade or glucosidase in the subtitle of 2.8.1? 9. For statistics, two-way ANOVA is preferable to obtain p value. Reviewer #3: Dear writers, the article is very well written, it was possible to make a practical and very precise reading, coherently relating the results and discussing them with precision. Like all scientific work, we know that some errors end up passing through and we don't realize it, so I'll make some remarks about the article here. I noticed a few times in the articles that some acronyms or symbols are described differently. Ex: 98°C - 4oC. It would be of great interest to review the acronyms and symbols throughout the article in order to create a single standard for the presentation of the work. In addition, some spacing after punctuations and/or symbols are different in some moments of the article (Ex: Fig. 6A - Fig. 5 A). Please, review this too. in topic 2.2 treatment; the number of animals is spelled out, in which case it is correct to use "24". The title of item 2.8.1 is misspelled, "Intestinal α-glucosity" please correct for α-glucosidase. Finally, something that caught my attention was the significant differences (Ex: p<0.0001), it is not common to use the point to separate the integer part from the decimal part, this is only common in English-speaking countries. Therefore, the correct thing is to review all the significant differences represented in the article and replace the points with commas. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Ameliorating the impairment of glucose utilization in a high-fat diet-induced obesity model through the consumption of Tucum-do-Cerrado (Bactris Setosa Mart.) PONE-D-23-20187R1 Dear Dr. Araújo, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Anand Thirupathi Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: All the previous questions were addressed. I appreciate the great efforts taken to visualize the data in graphs. The legends of graph in individual figures (i.e., a, b, c, etc., of figures) are not consistent throughout the manuscript. Do arrange the legends. Reviewer #2: The revised manuscript has corrected the errors in the tables and figures and results descriptions, and the statistics methods have been used as required. Moreover, the main components of Tucum-do-Cerrado that may exert the protective effect have also been discussed at the end of the revised manuscript. Therefore, the present form of manuscript has been been improved a lot, which could be considered for acception. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Kannathasan Thetchinamoorthy Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-23-20187R1 Ameliorating the impairment of glucose utilization in a high-fat diet-induced obesity model through the consumption of Tucum-do-Cerrado (Bactris Setosa Mart.) Dear Dr. Araújo: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Anand Thirupathi Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .